Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches
about
Depression masquerading as chest pain in a patient with Wolff Parkinson White syndrome.Associations between serum homocysteine levels and anxiety and depression among children and adolescents in Taiwan.The Discriminative Stimulus Properties of Drugs Used to Treat Depression and Anxiety.Cross-sectional Comparison of the Epidemiology of DSM-5 Generalized Anxiety Disorder Across the Globe.Latent variable analysis of positive and negative valence processing focused on symptom and behavioral units of analysis in mood and anxiety disorders.Antidepressant and anxiolytic activity of Lavandula officinalis aerial parts hydroalcoholic extract in scopolamine-treated rats.Total Saikosaponins of Bupleurum yinchowense reduces depressive, anxiety-like behavior and increases synaptic proteins expression in chronic corticosterine-treated mice.There is more to mental illness than negative affect: comprehensive temperament profiles in depression and generalized anxiety.Remission in Depression and Associated Factors at Different Assessment Times in Primary Care in Chile.Urinary biomarker panel for diagnosing patients with depression and anxiety disordersFactors Associated with Psychiatric Comorbidity in Depression Patients in Primary Health Care in ChileSafety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety
P2860
Q37334717-0210FF1C-E3A5-488D-B54C-DE131B71C51FQ38615327-1315BF02-0382-4749-B418-EF3C85DA9B14Q38847601-7E9C7F08-8E73-4DC3-AF7C-3684252208A4Q38905913-7A06E67F-97E3-41F5-B95F-2E8D67F7A88AQ38993769-4534A53B-C123-4594-8394-BBC9ACD9EC24Q47346260-6A7949A4-D723-4B6D-8147-C866D53CF0E2Q54118164-FE6860D6-7132-4DBC-93E0-8132F71276FFQ55057934-8BC1CAE0-88F1-4BD3-8AE9-D30F87631056Q55279690-131994B7-C53B-4AD4-B00B-85885BF4B31CQ57155162-69FE6D49-47F4-4BDB-B5D6-A1BACE070D73Q58591138-55485A96-808C-44C5-B43C-92DF86BE2E20Q58781967-DFA3D4F8-320F-404B-89FE-0F3AAE9E4E60
P2860
Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches
@ast
Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches
@en
Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches
@nl
type
label
Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches
@ast
Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches
@en
Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches
@nl
prefLabel
Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches
@ast
Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches
@en
Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches
@nl
P2093
P2860
P3181
P356
P1476
Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches
@en
P2093
Cindy J Aaronson
Jeremy D Coplan
Venkatesh Panthangi
Younsuk Kim
P2860
P304
P3181
P356
10.5498/WJP.V5.I4.366
P407
P577
2015-12-22T00:00:00Z